Rchr
J-GLOBAL ID:201701012725246390   Update date: Aug. 02, 2024

HISAKAZU KATO

カトウ ヒサカズ | HISAKAZU KATO
Affiliation and department:
Research field  (1): Cardiology
Research theme for competitive and other funds  (7):
  • 2024 - 2027 Identification of therapeutic targets for heart failure and development of intervention methods related to the control mechanism of cardiac pump function
  • 2020 - 2023 ATP産生制御因子の安定化によるミトコンドリア病の新規治療薬開発に向けた基盤研究
  • 2018 - 2020 G0S2を分子標的としたATP合成酵素活性化剤による新規心不全治療法の開発
  • 2017 - 2020 Development of novel therapeutic strategy for ischemic heart diseases through targeting protein degradation
  • 2015 - 2017 Unraveling the mechanism by which G0S2 regulates mitochondrial ATP production under ischemia
Show all
Papers (40):
  • Yusuke Katsuma, Isao Matsui, Ayumi Matsumoto, Hiroki Okushima, Atsuhiro Imai, Yusuke Sakaguchi, Takeshi Yamamoto, Masayuki Mizui, Shohei Uchinomiya, Hisakazu Kato, et al. Endogenous activation of peroxisome proliferator-activated receptor alpha in proximal tubule cells in counteracting phosphate toxicity. American journal of physiology. Renal physiology. 2024
  • Shinji Tokuyama, Hisakazu Kato, Hidekazu Takahashi, Kyoko Ueda, Asami Arita, Ryuta Ueda, Hiroto Seto, Yuki Sekido, Tsuyoshi Hata, Atsushi Hamabe, et al. BRAF V600E-induced distinct DNA damage response defines the therapeutic potential of p53 activation for TP53 wild-type colorectal cancer. Carcinogenesis. 2024
  • Mengying Cui, Koji Yamano, Kenichi Yamamoto, Hitomi Yamamoto-Imoto, Satoshi Minami, Takeshi Yamamoto, Sho Matsui, Tatsuya Kaminishi, Takayuki Shima, Monami Ogura, et al. HKDC1, a target of TFEB, is essential to maintain both mitochondrial and lysosomal homeostasis, preventing cellular senescence. Proceedings of the National Academy of Sciences. 2024. 121. 2
  • Hironori Yamamoto, Yohei Miyashita, Hitoshi Minamiguchi, Kazuyoshi Hosomichi, Shohei Yoshida, Hidetaka Kioka, Haruki Shinomiya, Haruno Nagata, Kenji Onoue, Masato Kawasaki, et al. Human leukocyte antigen-DQ risk heterodimeric haplotypes of left ventricular dysfunction in cardiac sarcoidosis: an autoimmune view of its role. Scientific reports. 2023. 13. 1. 19767-19767
  • Tatsuro Hitsumoto, Osamu Tsukamoto, Ken Matsuoka, Junjun Li, Li Liu, Yuki Kuramoto, Shuichiro Higo, Shou Ogawa, Noboru Fujino, Shohei Yoshida, et al. Restoration of Cardiac Myosin Light Chain Kinase Ameliorates Systolic Dysfunction by Reducing Superrelaxed Myosin. Circulation. 2023. 147. 25. 1902-1918
more...
MISC (7):
more...
Lectures and oral presentations  (16):
  • 新鮮臨床検体を用いた大腸癌新規標的分子の探索
    (第81回日本癌学会学術総会 2022)
  • BRAF の活性化は心筋細胞の脱分化を誘導する
    (第68回日本生化学会近畿支部例会 2022)
  • ATP合成酵素活性化剤による虚血性心疾患治療法の開発
    (1. WISH&SEEDsマッチング会 ~大学SEEDsと企業WISHをモダリティと疾病領域の2軸で結ぶ初の取組み~ 2022)
  • p53活性化による新規大腸癌治療法の開発
    (第121回日本外科学会定期学術集会)
  • スクリーニングによるp53タンパク分解を標的とする抗腫瘍効果を示す新規化合物の同定
    (第120回日本外科学会定期学術集会 2020)
more...
Education (3):
  • 2004 - 2008 Osaka University Graduate School of Medicine Course of Medical Biosignaling
  • 2002 - 2004 Osaka University Graduate School of Medicine Division of Health Sciences
  • 1998 - 2002 Osaka University
Professional career (1):
  • 博士(医学) (大阪大学)
Work history (6):
  • 2017/04 - 現在 Osaka University Graduate School of Medicine
  • 2015/12 - 2017/03 Osaka University Graduate School of Medicine
  • 2013/07 - 2015/11 Osaka University Graduate School of Medicine
  • 2010/04 - 2013/06 大阪大学大学院医学系研究科 分子心血管医学 特任研究員
  • 2008/07 - 2010/03 財団法人医療機器センター 流動研究員
Show all
Association Membership(s) (4):
日本癌学会 ,  JAPANESE HEART FAILURE SOCIETY ,  THE JAPANESE BIOCHEMICAL SOCIETY ,  THE MOLECULAR BIOLOGY SOCIETY OF JAPAN
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page